Clinical Evidence for the Choice of the Direct Oral Anticoagulant in Patients with Atrial Fibrillation According to Creatinine Clearance

Atrial fibrillation (AF) often coexists with chronic kidney disease (CKD), which confer to the patient a higher risk of both thromboembolic and hemorrhagic events. Oral anticoagulation therapy, nowadays preferably with direct oral anticoagulants (DOACs), represents the cornerstone for ischemic strok...

Descripción completa

Detalles Bibliográficos
Autores principales: Vio, Riccardo, Proietti, Riccardo, Rigato, Matteo, Calò, Lorenzo Arcangelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003529/
https://www.ncbi.nlm.nih.gov/pubmed/33808739
http://dx.doi.org/10.3390/ph14030279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003529/
https://www.ncbi.nlm.nih.gov/pubmed/33808739
http://dx.doi.org/10.3390/ph14030279

Ejemplares similares